SCI & TECH● LOWAug 19 · Aug 19, 2026, 9:43 PM
Ultragenyx wins accelerated approval of gene therapy for glycogen storage disease
Seeking Alpha Tech
Ultragenyx has received accelerated approval for its new gene therapy, intended to treat glycogen storage disease.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH38m agoWhy China’s new estimate on Greenland ice loss speed is 55% lower than America’sSouth China Morning PostSCI & TECH1h agoChristopher Johnson, marine scientist on blue whale conservation: "The decisions we make now will influence that recovery"ClarínSCI & TECH1h agoHow AI is transforming hurricane forecastsNPR NewsSCI & TECH1h agoWhat are microchimeric cells doing to our brain?New Scientist